Lupus Therapeutics, Affiliate of Lupus Research Alliance, Developing a Study Focused on Lupus Patients and COVID-19
New York, NY, April 7, 2020 – Lupus Therapeutics, the clinical trial affiliate of the Lupus Research Alliance (LRA),...
Pressroom
Recent Press Releases
MARCH 26 STATEMENT: Lupus Research Alliance Puts Plaquenil (Hydroxychloroquine) Shortage into Perspective for Lupus Community
March 26, 2020
The Lupus Research Alliance (LRA), the world’s leading research organization dedicated to lupus research, continues to watch...
New Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis
December 17, 2019
The Lupus Research Alliance is thrilled to share exciting news from GSK that Benlysta (belimumab) demonstrated positive...
Lupus Research Alliance 2019 Breaking Through Gala Raises $3 Million for Lupus Research
November 26, 2019 – New York, NY – The Lupus Research Alliance (LRA) 2019 Breaking Through Gala gathered more...
Lupus Research Alliance Response to Positive Data from Phase 3 Anifrolumab Trial Presented at 2019 ACR/ARP Annual Meeting
NEW YORK, NY – November 11. The Lupus Research Alliance (LRA) congratulates AstraZeneca on new positive results from the...
Lupus Research Alliance Response to Positive Trial Testing Obinutuzumab (Gazyva®) for Lupus Nephritis
NEW YORK, Nov. 10, 2019 /PRNewswire/ -- The Lupus Research Alliance (LRA) is pleased to acknowledge positive results presented by...
LRA Applauds Exciting Lupus Research Being Presented at 2019 ACR/ARP Annual Meeting
Includes 16 presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways
Results...
Lupus Research Alliance Announces 2019 Distinguished Innovator Awards Aimed at New Lupus Treatments
NEW YORK, October 24 -- The Lupus Research Alliance proudly announces two exceptional recipients of the 2019 Dr. William E....
Lupus Research Alliance Welcomes New Senior Director of Marketing and Communications
NEW YORK, NY. October 16 -- The Lupus Research Alliance (LRA) is pleased to announce that seasoned professional Penny...
MOMENTOUS NEWS — Potential New Lupus Treatment Effectively Reduced Disease Activity in Phase III Trial
NEW YORK, NY. August 29 -- The Lupus Research Alliance is excited to share the good news that a...
Dr. Daniel Wallace Appointed to Lupus Therapeutics Board
New York, NY, July 18, 2019 — Renowned Dr. Daniel Wallace joined the Lupus Research Alliance (LRA) affiliate Lupus Therapeutics Board of Directors. ...
Lupus Therapeutics Expands Collaboration with Bristol-Myers Squibb to Test Potential Treatment for Lupus
New York, NY– June 27, 2019. The Lupus Research Alliance (LRA) and clinical research affiliate, Lupus Therapeutics, broadened a collaboration...